MedTrace Logo

Decreased Neuraxial Morphine After Cesarean Delivery

NCT04279054 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 87

Last updated 2025-03-30

No results posted yet for this study

Summary

The purpose of this study is to compare 50mcg to 150mcg morphine in epidural for the goal of decreasing side effects of medication with lower dose in patients who receive a QL block

Conditions

  • Anesthesia

Interventions

DRUG

Morphine Sulfate 150 mcg

Use of 150mcg of morphine sulfate for neuraxial block (dosing difference)

DRUG

Morphine Sulfate 50mcg

Use of 50mcg of morphine sulfate for neuraxial block (dosing difference)

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Ayodeji Sanusi, MD · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-09
Primary Completion
2023-07-05
Completion
2023-07-05
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04279054 on ClinicalTrials.gov